Who invested in Kylin Therapeutics?
Kylin Therapeutics's investors include Golden Pine Ventures, In-vivo Ventures and Purdue University Endowment.
United States · Venture startup
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Kylin Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 7 Nov 2026
$2.1Mraised across 2 rounds since 2009, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $58K sold, first sale Nov 2009
Reported by lafayette-online.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Kylin Therapeutics's investors include Golden Pine Ventures, In-vivo Ventures and Purdue University Endowment.
Kylin Therapeutics has raised $2.1M across 2 rounds since 2009.
Kylin Therapeutics's most recent round was a Venture of $58K in Nov 2009.
Kylin Therapeutics's largest round on record is $2.0M (Venture), in Mar 2009.
Kylin Therapeutics's first round on record, in Mar 2009, was backed by Golden Pine Ventures, In-vivo Ventures and Purdue University Endowment.
Kylin Therapeutics's latest named round is a Venture, in Nov 2009.
Kylin Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.